CSIMarket
 
Viveon Health Acquisition Corp   (NYSE: VHAQ)
Other Ticker:  
 
 
Price: $11.0000 $1.00 10.000%
Day's High: $11 Week Perf: 1.76 %
Day's Low: $ 11.00 30 Day Perf: -3.11 %
Volume (M): 0 52 Wk High: $ 11.00
Volume (M$): $ 1 52 Wk Avg: $10.50
Open: $11.00 52 Wk Low: $10.00



 Market Capitalization (Millions $) 65
 Shares Outstanding (Millions) 6
 Employees 11
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Viveon Health Acquisition Corp
Viveon Health Acquisition Corp is a special purpose acquisition company (SPAC) focused on acquiring and merging with a targeted healthcare company. SPACs like Viveon Health Acquisition Corp are created with the sole purpose of raising capital through an initial public offering (IPO) in order to acquire an operating company. Once the acquisition is completed, the SPAC and the acquired company merge, allowing the acquired company to go public without going through the traditional IPO process. Viveon Health Acquisition Corp specifically targets companies within the healthcare industry, such as healthcare technology, medical device, or biotech companies, offering them a strategic partnership to enhance growth, access to capital, and a public market presence.


   Company Address: 3480 Peachtree Road NE Atlanta 30326 GA
   Company Phone Number: 861-5393   Stock Exchange / Ticker: NYSE VHAQ


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
HCAT   -0.38%    
TDOC        3.68% 
UNH   -3.05%    
• View Complete Report
   



Kaya Holdings Inc

Looking into fourth quarter of 2024 effort, the company's had

In its fourth quarter of 2024 financial report company reached break-even at $0.00 per share, opposite of $0.00 per share a year prior reporting period, In the prior reporting period Kaya Holdings Inc realized $-0.10 per share.

Regeneron Pharmaceuticals Inc

Double Digit Income per Share advance by 15.95 % at the REGN in first quarter of 2025

In spite of soft demand in the first quarter of 2025, company managed to improve its earnings per share, income increased by 15.95 % to $7.27 per share while revenue fell by -3.698 % to $3.03 billion, year on year.

Verona Pharma Plc

Verona Pharma Plc reported Revenue of $76.256 million, in the first quarter of 2025 earnings season

the Major Pharmaceutical Preparations company disclosed $76.256 million, in Revenue in the January to March 31 2025 fiscal time-frame.

Kiniksa Pharmaceuticals International Plc

Very stunning 72.538%, jump in revenue at the Major Pharmaceutical Preparations company over the fiscal time-frame closing March 31 2025

For the fiscal time-frame closing March 31 2025 Kiniksa Pharmaceuticals International Plc had turn a round to income by exhibiting EPS of $0.11 per share compare to $-0.25 a year ago and income per share turned positive from $-0.12 per share from the preceding reporting period. The revenue inched up strongly by 72.538 % to $137.79 million from $79.86 million in the corresponding reporting period a year ago and sequentially revenue advanced by 12.445 % from $122.54 million. Major Pharmaceutical Preparations company's results comes for many as a new revelation, while the KNSAs' exhibits revenue growth while rest of Major Pharmaceutical Preparations industries achieves -0.46% demise in business.

Sol Gel Technologies Ltd

Breaking down fourth quarter of 2024 results, the company's reported exceptional recent numbers

company announced very strong Revenue improvement of 642.471 % year on year to $11.54 million in the most recent fiscal period, but lost money at $-0.38. Sol Gel Technologies Ltd s' revenue, growth in the fourth quarter of 2024 correlates advantageously to its Major Pharmaceutical Preparations sector contemporaries, which reported on average 11.85 % top-line improvement during the matching time yet.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com